Engineering Extracellular Matrix-Bound Nanovesicles Secreted by Three-Dimensional Human Mesenchymal Stem Cells

Area of Science:

• Biomaterials Science
• Cell Biology
• Nanotechnology

Background:

• Extracellular matrix (ECM) contains matrix-bound nanovesicles (MBVs) that play functional roles in vivo.
• MBVs may recapitulate aspects of the native tissue microenvironment.
• Understanding MBVs is crucial for developing advanced biomaterials and cell-free therapies.

Purpose of the Study:

• To isolate and characterize matrix-bound nanovesicles (MBVs) from 3D human mesenchymal stem cells.
• To compare MBVs with extracellular vesicles from culture supernatants (SuEVs).
• To investigate the functional potential of MBVs in tissue repair and immune modulation.

Main Methods:

• Isolation of SuEVs and MBVs from 3D human mesenchymal stem cells.
• Nanoparticle tracking analysis and transmission electron microscopy for characterization.
• Western blot for marker analysis and miRNA profiling.
• In vitro functional assays including organoid recovery, fibroblast proliferation, and macrophage polarization.

Main Results:

• MBVs are smaller (100-150 nm) and morphologically distinct from SuEVs, with lower expression of some SuEV markers.
• The 3D microenvironment influences miRNA expression in MBVs (e.g., miR-19a, miR-21).
• MBVs promote forebrain organoid recovery and fibroblast proliferation.
• 3D MBVs enhance anti-inflammatory IL-10, while 2D MBVs suppress pro-inflammatory IL-12β in macrophages.

Conclusions:

• MBVs represent a distinct population of nanovesicles with unique properties compared to SuEVs.
• MBVs possess therapeutic potential for tissue regeneration and treating neurological disorders.
• Further research into MBVs can advance the design of novel cell-free therapies.